Lv4
700 积分 2023-04-25 加入
Tolvaptan, an Orally Active Vasopressin V2‐Receptor Antagonist—Pharmacology and Clinical Trials
9天前
已完结
OPC-41061, a Highly Potent Human Vasopressin V2-Receptor Antagonist: Pharmacological Profile and Aquaretic Effect by Single and Multiple Oral Dosing in Rats
10天前
已完结
Glycosphingolipid metabolism and polycystic kidney disease
1个月前
已完结
Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease
1个月前
已完结
Therapeutic advances in ADPKD: the future awaits
1个月前
已完结
Targeting the transferrin receptor to transport antisense oligonucleotides across the mammalian blood-brain barrier
3个月前
已完结
Systematic comparisons of various markers for mast cell activation in RBL-2H3 cells
4个月前
已完结
Comparative analyses of various IgE-mediated and non-IgE-mediated inducers of mast cell degranulation for in vitro study
4个月前
已完结
Flow cytometry–based basophil and mast cell activation tests in allergology: State of the art
5个月前
已完结
Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcεRI or FcγRI
5个月前
已完结
皖公网安备34019202002308
